LPL Financial’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$80M Buy
415,283
+252,905
+156% +$27.3M 0.02% 791
2026
Q2
$11.4M Sell
162,378
-15,662
-9% -$810K ﹤0.01% 2017
2026
Q1
$9.04M Sell
178,040
-46,119
-21% -$2.15M ﹤0.01% 2071
2025
Q4
$6.61M Sell
224,159
-14
-0% -$380 ﹤0.01% 2295
2025
Q3
$5.79M Buy
224,173
+39,010
+21% +$1.09M ﹤0.01% 2338
2025
Q2
$5.11M Sell
185,163
-491,049
-73% -$12.9M ﹤0.01% 2289
2025
Q1
$19.2M Buy
676,212
+308,334
+84% +$10.9M 0.01% 1173
2024
Q4
$15.3M Buy
367,878
+265,982
+261% +$12.7M 0.01% 1239
2024
Q3
$6.81M Sell
101,896
-10,217
-9% -$938K ﹤0.01% 1749
2024
Q2
$13.3M Buy
112,113
+7,998
+8% +$1.01M 0.01% 1187
2024
Q1
$11.1M Buy
104,115
+11,595
+13% +$1.17M 0.01% 1265
2023
Q4
$9.2M Sell
92,520
-23,262
-20% -$1.96M 0.01% 1305
2023
Q3
$12M Buy
115,782
+7,811
+7% +$871K 0.01% 1058
2023
Q2
$13.1M Buy
107,971
+10,239
+10% +$1.37M 0.01% 991
2023
Q1
$15M Sell
97,732
-3,614
-4% -$596K 0.01% 887
2022
Q4
$18.2M Buy
101,346
+4,430
+5% +$724K 0.02% 747
2022
Q3
$11.5M Sell
96,916
-7,390
-7% -$1.12M 0.01% 889
2022
Q2
$14.9M Sell
104,306
-838
-0.8% -$120K 0.01% 764
2022
Q1
$18.1M Sell
105,144
-15,053
-13% -$2.53M 0.02% 709
2021
Q4
$30.5M Sell
120,197
-29,864
-20% -$8.73M 0.03% 506
2021
Q3
$57.8M Buy
150,061
+24,239
+19% +$8.94M 0.05% 316
2021
Q2
$29.6M Buy
125,822
+10,712
+9% +$1.91M 0.03% 455
2021
Q1
$15.1M Sell
115,110
-9,358
-8% -$1.36M 0.02% 646
2020
Q4
$13M Sell
124,468
-15,733
-11% -$1.59M 0.02% 626
2020
Q3
$9.9M Buy
140,201
+60,120
+75% +$4.19M 0.02% 649
2020
Q2
$5.14M Buy
80,081
+22,327
+39% +$1.22M 0.01% 864
2020
Q1
$1.73M Buy
+57,754
New +$1.33M ﹤0.01% 1285

Other funds holding MRNA

LPL Financial's MRNA Position: Q3 2026 in Review

LPL Financial increased its Moderna (MRNA) stake by 156% in Q3 2026, buying an estimated $27.3M and bringing the position to 415,283 shares worth $80M. The position accounts for 0.02% of the portfolio, ranked #791.

LPL Financial first reported a position in MRNA in Q1 2020 and has held it in 27 quarters since. 1,045 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • LPL Financial held 415,283 shares of Moderna worth $80M as of Q3 2026.
  • LPL Financial bought 252,905 Moderna shares in Q3 2026, an estimated $27.3M.
  • Moderna made up 0.02% of LPL Financial's portfolio in Q3 2026, its #791 holding.
  • LPL Financial first reported a position in Moderna in Q1 2020 and has held it in 27 quarters since.
  • 1,045 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.